Skip to main content
FONAR CORP logo

FONAR CORP — Investor Relations & Filings

Ticker · FONR ISIN · US3444374058 US Manufacturing
Filings indexed 556 across all filing types
Latest filing 2005-07-15 Interim / Quarterly Rep…
Country US United States of America
Listing US FONR

About FONAR CORP

https://www.fonar.com/

FONAR Corporation designs, manufactures, sells, and services magnetic resonance imaging (MRI) scanners. A pioneer in the field, the company developed the world's first commercial MRI. Its flagship product is the UPRIGHT® Multi-Position™ MRI, the only scanner capable of imaging patients in various weight-bearing positions, such as standing, sitting, or bending, in addition to the traditional recumbent position. This technology enables the diagnosis of pathologies that may be missed on conventional lie-down MRI systems by scanning patients in the position where they experience symptoms. The scanner's open configuration also accommodates claustrophobic and larger patients.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2005
Interim / Quarterly Report
2005-07-15 English
Interim / Quarterly Report 2005
Interim / Quarterly Report
2005-06-28 English
Annual Report 2005
Annual Report
2005-06-24 English
Interim / Quarterly Report 2005
Interim / Quarterly Report
2005-06-24 English
Regulatory Filings 2005
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from Fonar Corporation to the SEC regarding comments on their Form 10-K for the fiscal year ended June 30, 2004, and Form 10-Q for the quarter ended December 31, 2004. It addresses specific comments on financial disclosures, accounting policies, liquidity, management agreements, and internal controls. The letter references amendments to these Exchange Act reports being filed concurrently. The content is primarily a regulatory response and commentary on filings rather than the filings themselves. The document length is about 12,000 characters, which is substantial but the content is a letter responding to SEC comments, not the actual 10-K or 10-Q report. According to the rules, such a letter is best classified as a Regulatory Filing (RNS) because it is a compliance document responding to regulatory comments and not the actual financial report or audit report itself.
2005-06-07 English
Regulatory Filings 2005
Regulatory Filings
2005-05-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.